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Abstract
Background: Sickle cell anemia causes severe complications and premature death. Five common β-globin gene
cluster haplotypes are each associated with characteristic fetal hemoglobin (HbF) levels. As HbF is the major modulator
of disease severity, classifying patients according to haplotype is useful. The first method of haplotype classification used
restriction fragment length polymorphisms (RFLPs) to detect single nucleotide polymorphisms (SNPs) in the β-globin
gene cluster. This is labor intensive, and error prone.
Methods: We used genome-wide SNP data imputed to the 1000 Genomes reference panel to obtain phased data
distinguishing parental alleles.
Results: We successfully haplotyped 813 sickle cell anemia patients previously classified by RFLPs with a concordance
>98%. Four SNPs (rs3834466, rs28440105, rs10128556, and rs968857) marking four different restriction enzyme sites
unequivocally defined most haplotypes. We were able to assign a haplotype to 86% of samples that were either partially
or misclassified using RFLPs.
Conclusion: Phased data using only four SNPs allowed unequivocal assignment of a haplotype that was not always
possible using a larger number of RFLPs. Given the availability of genome-wide SNP data, our method is rapid and does
not require high computational resources.
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Background
Sickle cell anemia affects millions worldwide and is
associated with high morbidity and mortality [1]. The con-
centration of fetal hemoglobin (HbF) is the main patho-
physiological modulator [2]. Five major haplotypes of the
β-globin gene (HBB) cluster are associated with different
levels of HbF [3, 4]. Patients with the highest HbF gener-
ally have the mildest disease [5, 6]. Therefore, classifica-
tion of patients’ haplotype is useful for prognostic
purposes and for studying the genetic differences that
contribute to the HbF variability among these haplotypes.
Haplotypes of sickle cell anemia were first ascertained
by analysis of restriction fragment length polymorphisms
(RFLPs) in the HBB gene cluster [7]. This classification
was based on detecting whether or not cleavage occurred
at five to eight restriction sites when DNA was digested
with restriction endonucleases, as shown in Fig. 1 [8–10].
This method is time-consuming and can lead to error
[10]. Fluorescence resonance energy transfer coupled with
high-resolution melting (HRM) assay is another method
to classify sickle cell haplotypes, but it is also labor inten-
sive and requires multiple laboratory assays [10]. Neither
method is capable of differentiating between parental and
maternal alleles in an individual so that without inform-
ative genetic data from family members, the phasing of
restriction patterns is not possible, and in many cases
ascertainment of a haplotype is either equivocal or impos-
sible. We used genome-wide association study (GWAS)
data imputed to a reference panel to obtain a phased out-
put. The phased GWAS data allowed assigning SNPs to
parental chromosomes, which facilitated the classification
procedure using fewer SNPs.
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Methods
Haplotype classification
GWAS data were available for patients with sickle cell
anemia from the Cooperative Study of Sickle Cell Dis-
ease (CSSCD) [11]. SNP array data containing 588,451
markers were evaluated using PLINK to identify and re-
move SNPs with minor allele frequency (MAF) < 0.01,
that violated Hardy-Weinberg Equilibrium (HWE), and
had more than 0.05 missing genotype information [12].
Genotypes for a total of 560,170 SNPs were imputed
using the Michigan Imputation Server [13], the 1000
Genomes Phase 3 v5 reference panel, and the Eagle
phasing algorithm to obtain phased output [14, 15]. We
developed a Python script based on VCF and PYSAM
Python modules to read SNP information and assign the
haplotype accordingly [16, 17]. Code and an example are
available on GitHub (https://github.com/eshaikho/haplo-
typeClassifier). We used this script to classify 1394 sam-
ples that were previously classified by RFLP in the
CSSCD. We selected four SNPs (rs3834466, rs28440105,
rs10128556, and rs968857) which define all of the haplo-
types spanning the β-globin gene cluster (Table 1).
Calculation of HbF average per haplotype
To check the consistency of classification and average HbF
for each haplotype, we used samples with available HbF
level information including 559 of the 813 samples that
were successfully classified with RFLPs, 916 of the samples
classified with SNP-based methodology, and 252 of samples
that were either partially classified or failed classification
Fig. 1 Restriction Enzyme Recognition Sites in the β-Globin Gene Cluster. RSIDs of SNPs present in restriction endonuclease sites in the β-globin-
like gene cluster. (+) denotes the presence of the corresponding enzyme site while (−) denotes the absence in the five-major sickle cell haplotype
(Benin (BEN), Central African Republic (CAR), Senegal (SEN), Cameroon (CAM) and Arab–Indian (AI)
Table 1 Five Major Haplotypes and Alleles of the Four SNPs
Defining the Haplotype
Haplotype rs3834466 rs28440105 rs10128556 rs968857
AI GT C T T
SEN G C T T
BEN G C C T
CAR G C C C
CAM G A C T
Table 2 Comparison of Haplotype Classification Methods for
813 Sickle Cell Anemia Patients from the CSSCD
Haplotype 5 RFLPs 4 SNPs Concordance
BEN/BEN 371 367 0.989218329
BEN/CAR 226 224 0.991150442
BEN/SEN 91 91 1
BEN/CAM 41 41 1
CAR/CAR 31 31 1
CAR/SEN 17 17 1
CAR/CAM 14 14 1
SEN/CAM 9 9 1
SEN/SEN 8 8 1
BEN/AI 2 0 0
CAR/AI 1 1 1
SEN/AI 1 1 1
CAM/CAM 1 1 1
Five RFLP represents haplotypes previously assigned by RFLPs using information
from 5 restriction sites based on Southern blotting. 4 SNPs represents the number
of haplotypes assigned using the phased SNP-based classification
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with RFLPs. We calculated the average HbF level for each
haplotype using psych R package [18], and generated a
boxplot for the most common haplotypes (Benin homozy-
gotes [BEN/BEN], Benin/Central African Republic com-
pound heterozygotes [BEN/CAR], Benin/Senegal compound
heterozygotes [BEN/SEN], Benin/Cameroon compound het-
erozygotes [BEN/CAM], Central African Republic homozy-
gotes [CAR/CAR]) in this cohort to show the consistency
of HbF levels across the three groups (five RFLP classifica-
tion, SNP-based classification, and the group that failed
five RFLP classification but were able to be classified with
the SNP-based method).
Classification of haplotypes in Saudi sickle cell anemia
patients and in a library of sickle cell anemia induced
pluripotent stem cells (iPSCs)
Since CSSCD patients are mostly African American, we
tested our method using data obtained from sickle cell
anemia patients from the Eastern and Southwestern
Table 3 Mean HbF Levels Among Haplotypes
aCSSCD
RFLP classification SNP-based classification Failed RFLP classification
Haplotype n mean sd n mean sd n mean sd
BEN/BEN 253 6.69 5.58 379 6.39 5.14 89 6.07 4.32
BEN/CAR 157 7.32 7.63 261 7.04 6.77 74 6.83 5.37
BEN/SEN 62 8.18 4.75 116 7.99 5.32 33 7.72 5.50
BEN/CAM 32 4.81 3.89 53 5.33 5.19 15 6.06 6.18
CAR/CAR 21 5.52 3.71 41 5.59 3.90 16 5.66 4.47
CAR/SEN 11 9.80 3.48 24 8.91 7.59 7 11.24 13.14
CAR/CAM 9 3.80 2.51 18 3.96 3.24 8 4.41 4.16
SEN/SEN 7 9.24 5.30 13 8.74 4.35 5 7.58 3.35
CAM/SEN 3 7.43 6.23 9 8.61 6.02 5 9.24 7.17
BEN/AI 2 4.20 5.37 - - - - - -
CAM/CAM 1 7.00 - 1 7.00 - - - -
CAR/AI 1 16.10 - 1 16.10 - - - -
bSW Saudi
RFLP classification SNP-based classification Failed RFLP classification
Haplotype n mean sd n mean sd n mean sd
BEN/BEN 39 11.22 5.32 48 10.28 4.19 - - -
CAR/CAR 11 9.35 5.07 - - - - - -
BEN/SEN 2 8.65 0.64 - - - - - -
BEN/CAR 1 6.50 - 1 3.10 - - - -
SEN/SEN 1 20.40 - - - - - - -
UNK 1 12.60 - - - - - - -
AI/AI - - - 1 20.40 - - - -
BEN/CAM - - - 2 10.15 9.69 - - -
BEN/UNK - - - 3 20.20 8.64 - - -
cE Saudi
RFLP classification SNP-based classification Failed RFLP classification
Haplotype n mean sd n mean sd n mean sd
AI/AI 30 18.03 5.39 30 18.03 5.39 - - -
Included are 559 patients with HbF phenotypes classified with RFLP method, 916 patients with HbF phenotypes classified with SNP-based method, and 252 samples
that failed RFLP classification but were classifiable with SNP-based method. (n) is the number of patients in the corresponding haplotype class, (mean) is the mean of
HbF per haplotype, (sd) is the standard deviation. aCSSCD are African Americans; bSW Saudi is Saudi patients from Southwestern Province; cE Saudi are Saudi patients
from the Eastern Province. UNK-unknown
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Provinces of Saudi Arabia. Eastern Province patients
tend to have the autochthonous Arab Indian (AI) haplo-
type as the major haplotype, while Southwestern Prov-
ince patients mostly have the BEN haplotype that was
introduced from Africa. The HbF levels in Saudi Benin
patients is twice as high as African American patients
with this haplotype [2, 19]. To further test our method on
a mixed population of diverse ethnicity we reclassified
haplotypes originally ascertained using RFLPs in a library
of sickle cell anemia-derived iPSCs [20].
Results
Haplotype classification
Of 371 CSSCD patients classified as BEN/BEN using five
RFLPs, we achieved a concordance of 98% (367/371)
using four phased SNPs. We achieved >99% concord-
ance for patients classified as BEN/CAR using RFLPs.
For BEN/SEN, BEN/CAM, CAR/CAR, CAR/SEN, CAR/
CAM, CAR/AI, SEN/SEN, SEN/CAM, SEN/AI, and
CAM/CAM haplotypes our concordance with the RFLP
method was 100% although the numbers of patients in
each category was smaller. Two patients classified ori-
ginally as BEN/AI failed reclassification (Table 2).
Discordance between our method and the five RFLP
method occurred in only eight of 813 patients providing
an overall concordance rate > 99%. Two patients
classified as BEN/AI with RFLP were reclassified as UN-
KNOWN/SEN. Four patients classified as BEN/BEN
were reclassified as UNKNOWN/BEN, CAR/CAR,
CAM/BEN, and SEN/BEN. The last two patients were
classified as CAR/SEN and SEN/BEN with our methods
instead of BEN/CAR according to RFLP analysis. Im-
portantly, we were able to assign a haplotype to 86%
(343/ 395) of samples from the CSSCD that failed classi-
fication using RFLPs.
Calculation of HbF average per haplotype
The average haplotype HbF level of patients classified with
our method is consistent with average HbF in haplotypes
reported in literature based on RFLPs (Table 3) [5, 6]. The
average haplotype HbF for samples unclassifiable using
RFLPs, but classified using phased SNP data matched the
average HbF for each known haplotype (Table 3). Boxplots
of the most common five haplotypes in the CSSCD cohort
show the consistency of HbF levels across the three classi-
fication groups (Fig. 2).
Classification of haplotype in Saudi sickle cell anemia and
sickle iPSCs
Haplotypes among 55 Southwestern Province patients
classified using the RFLP method included 39 BEN/BEN,
11 CAR/CAR, 2 BEN/SEN, 1 BEN/CAR, 1 SEN/SEN
and one unknown. The distribution of haplotypes for
these subjects derived using the SNP method was 48
BEN/BEN, 3 BEN/UNKNOWN, 2 BEN/CAM, and one
AI/AI (Table 3). The concordance between RFLP and
SNP-based classification was 67%. For the 30 Eastern
Fig. 2 Boxplots of the Common Haplotypes in the CSSCD. Shown are the HbF levels according to haplotype defined by RFLPs and SNP-based
methodology. The third panel shows data from patients not classified by RFLP but successfully classified using the SNP-based method. The black
dots in the middle of the boxplots represent mean HbF level, while the black horizontal lines represent the median HbF level
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Table 4 Sickle Anemia-Specific iPSC Library
Name of Line Gender Nationality of Origin Age Haplotype 4SNPs
SA108 male Saudi Arabia 9 AI/AI AI/AI
SA50-1 female Saudi Arabia NA AI/AI AI/AI
SA106-1 female Saudi Arabia NA AI/AI AI/AI
SA170-1 male Saudi Arabia 3 AI/AI AI/AI
SS2-1 female US 32 UNK/UNK BEN/SEN
SS2-1GAG (CRISPR corrected) female US 32 UNK/UNK BEN/SEN
SS12-1 female US 27 UNK/UNK BEN/CAR
SS18-1 female US 23 UNK/UNK UNK/UNK
SS28-1 female US 25 UNK/UNK BEN/BEN
SS36 male US 38 UNK/UNK BEN/CAR
SS41-1 male US 21 UNK/UNK CAR/CAR
SS45-1 female US 37 UNK/UNK BEN/BEN
SS47-1 female US 42 UNK/UNK BEN/CAR
SS48-1 male US 30 UNK/UNK CAR/CAR
SA5-1 female Saudi Arabia 9 UNK/UNK BEN/BEN
SA53-1 male Saudi Arabia 14 UNK/UNK BEN/CAR
SA208 male Saudi Arabia 7 UNK/UNK UNK/BEN
SA138-1 male Saudi Arabia 16 UNK/UNK AI/AI
BR-SP-21-1 female Brazil 20 UNK/UNK BEN/CAR
BR-SP-37-1 female Brazil 20 UNK/UNK CAR/CAM
BR-SP-45-1 female Brazil 20 UNK/UNK CAR/CAR
SS24-1 male US 24 CAR/CAR CAR/CAR
SS25-1 female US 22 CAR/CAR CAR/CAR
BR-SP-3-1 female Brazil 34 CAR/CAR CAR/CAR
BR-SP-23-1 female Brazil 23 CAR/CAR CAR/CAR
BR-SP-25-1 male Brazil 34 CAR/CAR CAR/CAR
BR-SP-41-1 male Brazil 22 CAR/CAR CAR/CAR
BR-SP-43-1 male Brazil 21 CAR/CAR CAR/CAR
SS9-1 female US 29 BEN/CAR BEN/CAR
SS13-1 female US 25 BEN/CAR BEN/CAR
SS15-1 female US 28 BEN/CAR BEN/CAR
SS35 male US 50 BEN/CAR BEN/CAR
BR-SP-29-1 male Brazil 20 BEN/CAR BEN/CAR
BR-SP-33-1 female Brazil 53 BEN/CAR BEN/CAR
BR-SP-39-1 male Brazil 22 BEN/CAR BEN/CAR
SS5-1 male US 32 BEN/BEN BEN/BEN
SS14-1 female US 39 BEN/BEN BEN/BEN
SS16-1 female US 36 BEN/BEN BEN/BEN
SS19-1 male US 30 BEN/BEN BEN/BEN
SS29-1 female US 32 BEN/BEN BEN/BEN
SS32 female US 33 BEN/BEN BEN/BEN
SS37 female US 37 BEN/BEN BEN/BEN
SS38 male US 26 BEN/BEN BEN/BEN
SS44-1 female US 23 BEN/BEN BEN/CAM
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Province patients, we had 100% concordance since all
patients reclassified as AI/AI (Table 3).
In a library of sickle cell anemia iPSCs there was high
concordance between the two methods of haplotype as-
certainment. The only discordance was in two patients
classified originally as BEN/BEN that according to SNP-
based reclassification were CAM/BEN and CAR/SEN
(Table 4). Importantly, we were able to assign a haplo-
type to 15 of 17 iPSC samples that were classified as ei-
ther atypical or were indeterminate using RFLPs.
Discussion
In adults, homozygotes for the BEN, CAR, and CAM
haplotypes were associated with HbF of 5-7% of total
hemoglobin; SEN and AI haplotypes had HbF levels of
about 10% and 20%, respectively. Using GWAS data we
were able to classify with high accuracy and time effi-
ciency the haplotype of sickle cell anemia patients using
four SNPs. The primary feature of our classification
method is a phasing step after genotype imputation
where SNP alleles are assigned to parental chromo-
somes, and the haplotype of each chromosome is
assigned independently. This method was superior to as-
certaining haplotype by RFLP using unphased SNPs at
five sites and was successfully applied in a few seconds
on a personal computer.
Haplotyping errors can occur using the SNP-based
method because of the SNP genotyping platform, imput-
ation errors, and ambiguities arising from phasing algo-
rithms. Nevertheless, in African-origin patient samples,
we were able to achieve a concordance of 99% percent
(805/813) between 4-SNP haplotypes derived from a phas-
ing algorithm using GWAS data with 5-SNP haplotypes
determined using restriction analysis. Haplotype assign-
ment in a sickle cell anemia iPSC library also showed high
concordance and demonstrated the efficiency of SNP-
based method to classify samples that failed RFLP classifi-
cation. The discordance between SNP-based and RFLP as-
certainment most likely resulted from errors in the RFLP
classification that is sensitive to the presence of other
SNPs in the restriction sites and the vagaries of restriction
enzyme analysis and Southern blotting that was used for
haplotype analysis in the CSSCD.
In 30 Saudi East patients where the AI haplotype was
ascertained by genotyping rs7482144 (Xmn1 5′ to HBG2),
rs3834466 (Hinc2 5′ to HBE1), and rs549964658 (5′ to
HBD) we had 100% concordance.
The major discordance between RFLP and SNP-based
analysis for classification of Saudi Southwestern patients oc-
curred among 11 subjects classified as CAR/CAR. Eight of
these 11 were reclassified as BEN/BEN and three as BEN
heterozygotes. The only difference between CAR and BEN
haplotypes is the SNP rs968857 at the HincII site 5′ of
HBD (Fig. 1, Table 2). It is most likely that this discrepancy
was a result of an error in RFLP analysis. If the discordance
was due to imputation quality, the error rate would prob-
ably match the imputation error. There is 100% discord-
ance at this HincII site while the imputation quality score
of rs968857 is R2 = 0.99. One patient with HbF of 20.4%
originally as SEN/SEN by RFLP was reclassified as AI/AI.
To investigate the discordance in Southwestern Province
patients, we examined the genotype data of the HBB gene
cluster downstream of OR51V1 (5′ olfactory receptor gene
cluster) and upstream of OR51B4 (3′ olfactory gene clus-
ter) in both patient groups. The SNP genotypes of the 11
CAR/CAR that we reclassified as BEN/BEN or BEN het-
erozygous had the same SNP genotype of BEN/BEN pa-
tients that were classified as such with both methods. The
genotype data, average HbF, and the imputation quality
score of rs968857 suggest that the high discordance in
Southwestern Saudi patients is due to RFLP errors.
A limitation of our method is the dependency on the
availability of GWAS data for many SNPs in the β-
Table 4 Sickle Anemia-Specific iPSC Library (Continued)
SS49-1 male US 31 BEN/BEN CAR/SEN
SA36 female Saudi Arabia 26 BEN/BEN BEN/BEN
SA40-1 male Saudi Arabia 20 BEN/BEN BEN/BEN
SA64 male Saudi Arabia 14 BEN/BEN BEN/BEN
SA82-2 male Saudi Arabia 24 BEN/BEN BEN/BEN
SA209-1 male Saudi Arabia 12 BEN/BEN BEN/BEN
SA210-1 male Saudi Arabia 9 BEN/BEN BEN/BEN
BR-SP-31-1 male Brazil 35 BEN/BEN BEN/BEN
SS4-1 male US 30 BEN/SEN BEN/SEN
SS8-2 female US 31 SEN/SEN SEN/SEN
SS43-2 female US 32 SEN/SEN SEN/SEN
Haplotype denotes the haplotype classification and 4 SNPs is SNP-based reclassification. The table is modified from [20]
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globin gene region. However, many large patient cohorts
have been genotyped using genome-wide SNP arrays. In
these patients, haplotype information might be useful as
a covariate in a genetic risk analysis. RFLP analysis might
be suitable for a small number of patients but requires
optimization of all of the individual assays. The main
advantage of our haplotype determination method is the
rapid classification and high accuracy. This method can
also be used for whole genome sequence data classifica-
tion after SNP calling and phasing. Moreover, it is not
sensitive to SNPs that alter the restriction enzyme recog-
nition sequence that can lead to error using RFLPs.
Conclusion
Phased data using only four SNPs allowed unequivocal
assignment of a β-globin gene cluster haplotype that was
not always possible using a larger number of RFLPs, and
was also more accurate. With the availability of genome-
wide SNP data our method is rapid and does not require
high computational resources.
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